AGABITI ROSEI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 41.540
EU - Europa 31.007
AS - Asia 18.970
SA - Sud America 167
AF - Africa 154
OC - Oceania 69
Continente sconosciuto - Info sul continente non disponibili 63
AN - Antartide 1
Totale 91.971
Nazione #
US - Stati Uniti d'America 41.407
CN - Cina 9.074
DE - Germania 7.745
UA - Ucraina 7.586
IT - Italia 4.663
HK - Hong Kong 3.901
SG - Singapore 3.071
RU - Federazione Russa 2.179
PL - Polonia 2.059
FI - Finlandia 1.851
GB - Regno Unito 1.766
IN - India 1.304
TR - Turchia 1.203
IE - Irlanda 1.155
FR - Francia 1.088
SE - Svezia 484
BR - Brasile 120
NL - Olanda 117
CA - Canada 116
MU - Mauritius 116
IR - Iran 74
BE - Belgio 72
VN - Vietnam 71
AU - Australia 62
EU - Europa 61
CZ - Repubblica Ceca 58
ID - Indonesia 52
JP - Giappone 42
RO - Romania 33
CH - Svizzera 27
AE - Emirati Arabi Uniti 17
PT - Portogallo 16
AR - Argentina 15
ES - Italia 14
MY - Malesia 14
CL - Cile 13
GE - Georgia 13
SA - Arabia Saudita 13
HU - Ungheria 12
AT - Austria 11
KZ - Kazakistan 11
TW - Taiwan 11
ZA - Sudafrica 11
KR - Corea 10
AM - Armenia 9
AZ - Azerbaigian 9
TH - Thailandia 9
AL - Albania 8
LK - Sri Lanka 8
MA - Marocco 8
BY - Bielorussia 7
DK - Danimarca 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
BO - Bolivia 6
PE - Perù 6
SK - Slovacchia (Repubblica Slovacca) 6
BD - Bangladesh 5
EE - Estonia 5
EG - Egitto 5
KG - Kirghizistan 5
KH - Cambogia 5
MX - Messico 5
NO - Norvegia 5
PA - Panama 5
SD - Sudan 5
AF - Afghanistan, Repubblica islamica di 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
IL - Israele 4
JO - Giordania 4
LA - Repubblica Popolare Democratica del Laos 4
PK - Pakistan 4
BA - Bosnia-Erzegovina 3
EC - Ecuador 3
GR - Grecia 3
IQ - Iraq 3
KW - Kuwait 3
LU - Lussemburgo 3
MD - Moldavia 3
PS - Palestinian Territory 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
CO - Colombia 2
CY - Cipro 2
HR - Croazia 2
IM - Isola di Man 2
IS - Islanda 2
JM - Giamaica 2
LT - Lituania 2
PH - Filippine 2
RS - Serbia 2
SI - Slovenia 2
TJ - Tagikistan 2
TN - Tunisia 2
VE - Venezuela 2
CR - Costa Rica 1
GS - Georgia del Sud e Isole Sandwich Australi 1
KE - Kenya 1
MZ - Mozambico 1
Totale 91.966
Città #
Jacksonville 5.726
Woodbridge 5.084
Fairfield 4.492
Hong Kong 3.887
Houston 3.429
Ann Arbor 2.791
Ashburn 2.663
Singapore 2.481
Nanjing 2.311
Princeton 2.210
Cambridge 2.110
Wilmington 2.102
Warsaw 2.050
Chandler 1.873
Seattle 1.714
Dublin 1.151
Beijing 1.139
Istanbul 1.000
Nanchang 843
Helsinki 724
Moscow 632
Shenyang 563
Des Moines 521
New York 518
Hebei 486
Changsha 445
Jinan 430
Milan 426
Tianjin 402
Shanghai 366
Jiaxing 341
Dearborn 318
Kunming 277
San Diego 273
Nürnberg 218
Verona 214
Rome 199
Hangzhou 198
Grafing 182
Ningbo 182
Los Angeles 168
Lancaster 162
Brescia 156
Kocaeli 155
Lanzhou 149
Zhengzhou 147
San Mateo 137
Haikou 131
Taizhou 120
Munich 115
San Francisco 114
Toronto 91
Changchun 87
Guangzhou 87
Augusta 81
Leawood 78
Taiyuan 78
London 73
Norwalk 69
Brussels 64
Dong Ket 58
Ardabil 56
Monmouth Junction 56
Washington 56
Fuzhou 51
Florence 50
Boardman 44
Brno 44
Naples 39
Bologna 36
Napoli 35
Saint Petersburg 35
Melbourne 33
Orange 33
Kilburn 32
Palermo 32
Jakarta 30
Pune 26
Redwood City 26
São Paulo 26
Bari 25
Turin 24
Mantova 23
Santa Clara 21
Padova 20
Tokyo 19
Catania 18
Chiswick 17
Hanover 17
Hefei 17
Messina 17
Phoenix 17
Canberra 16
Falkenstein 16
Genoa 16
Westminster 16
Berlin 15
Chicago 15
Frankfurt am Main 15
Monza 15
Totale 60.390
Nome #
Differenti metodi di calcolo della massa ventricolare sinistra e relativo significato prognostico. 1.760
Vasodilatazione flusso mediata della arteria brachiale e disfunzione endoteliale nelle piccole arterie di resistenza sottocutanee 479
Lo “smoothness index” è superiore al rapporto valle/picco nell’indicare una riduzione omogenea della pressione arteriosa nelle 24 ore e nel predire la regressione del danno d’organo indotte dalla terapia antiipertensiva 349
Structural Alterations of Small Resistance Arteries in Obesity 326
Lo “smoothness index” è superiore al rapporto valle/picco nell’indicare una riduzione omogenea della pressione arteriosa nelle 24 ore e nel predire la regressione del danno d’organo indotte dalla terapia antiipertensiva 309
A double-blind placebo-controlled trial of liquid thyroxine ingested at breakfast: Results of the TICO study 307
Il rapporto tra diametro antero-posteriore e diametro traverso nel nodulo tiroideo: parametro ecografico predittivo di malignità?. 288
Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk 277
Morbid Obesity in Women is Associated to a Lower Prevalence of Thyroid Nodules. 274
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 259
Role of heme oxygenase in modulating endothelial function in mesenteric small resistance arteries of spontaneously hypertensive rats. 257
Genetic mutation screening in an Italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients 254
The unusual clinical manifestation of thyroid storm. 231
Thyroglobulin measurement in fine-needleaspiration biopsy of metastatic lymph nodes after rhTSH stimulation. 231
Vasodilatazione e vasocostrizione endotelio-dipendente nelle piccole arterie sottocutanee di pazienti con diabete di II tipo, con o senza concomitante ipertensione arteriosa. 214
Fine needle cytology of complex thyroid nodules. 204
Decreased number of circulating endothelial progenitor cells in patients with Graves’ hyperthyroidism. 203
Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study 200
TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. 197
Close Relationship Between Media to Lumen Ratio of Subcutaneous Small Arteries and Wall to Lumen Ratio of Retinal Arterioles Evaluated Non Invasively By Scanning Laser Doppler Flowmetry 192
Modified percutaneous ethanol injection of parathyroid adenoma in primary hyperparathyroidism. 191
Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers 179
Carotid stiffness is significantly correlated with wall-to-lumen ratio of retinal arterioles. 179
Left ventricular hypertrophy and renal dysfunction during antihypertensive treatment adversely affect cardiovascular prognosis in hypertensive patients. 177
Usefulness of repeated recombinant human thyrotropin (rh-TSH) stimulated thyroglobulin test in the post-surgical follow-up of very low-risk patients with differentiated thyroid carcinoma. 169
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. 169
Resistant hypertension and target organ damage. 167
Correlation between wall-to-lumen ratio of retinal arterioles and clinic and 24 hours blood pressure 167
Inappropriate left ventricular mass changes during treatment adversely affects cardiovascular prognosis in hypertensive patients 164
Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension 164
How to assess microvascular structure in humans 161
Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists. 160
Adrenergic activity in systolic hypertension. 160
Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. 159
Vasodilator effects of red wines in subcutaneous small resistance artery of patients with essential hypertension. 157
Pulse wave velocity and cardiovascular risk stratification in a general population: the Vobarno study 155
Pulsatile Hemodynamics and Microcirculation: Evidence for a Close Relationship in Hypertensive Patients. 153
Effects of a long-term treatment with aliskiren or ramipril on structural alterations of subcutaneous small resistance arteries of diabetic hypertensive patients 153
Pulse wave velocity and cardiovascular risk stratification in a general population: The Vobarno study 152
Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients. 151
Treatment of hypertensive urgencies and emergencies 149
Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery. 148
Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome. 145
Genetic mutation screening in an Italian cohort of non-syndromic pheochromocytoma/paraganglioma patients. 144
Inappropriate left ventricular mass in patients with primary aldosteronism. 143
Reversal of cardiac hypertrophy by long-term treatment with calcium antagonists in hypertensive patients. 142
Renal noradrenergic and dopaminergic activity in patients with borderline essential hypertension. 141
Effects of prizidilol (SKF 92657) on blood pressure, haemodynamics, sympathetic nervous system activity and plasma volume in essential hypertension. 141
Renal noradrenergic and dopaminergic activity in patients with borderline essential hypertension. 141
Effect of short-term treatment with lercanidipine on circulating endothelial progenitor cells and structural alterations in retinal arterioles 141
Anticontractile activity of perivascular fat in obese mice and the effect of long-term treatment with melatonin. 141
Calliphora vicina human myiasis: a case report 141
Hypertensive crisis in patients with phaeochromocytoma given metoclopramide. 138
Vasodilatazione flusso mediata dell’arteria brachiale in pazienti ipertesi: significato prognostico 138
Platypnea and orthodeoxia in a patient with pulmonary embolism. 138
Identification of the hemodynamic modulators and hemodynamic status in uncontrolled hypertensive patients. 136
Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. 135
Renal and hemodynamic effects of atrial natriuretic peptide infusion are not mediated by peripheral dopaminergic mechanisms. 135
Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. 135
Is the 'sodium index' a useful way of expressing clinical plasma renin, angiotensin and aldosterone values? 135
Beneficial effects of one year's treatment with captopril on left ventricular anatomy and function in hypertensive patients with left ventricular hypertrophy. 133
Similarities and differences in the antihypertensive effect of two calcium antagonist drugs, verapamil and nifedipine. 132
Aortic rigidity and plasma catecholamines in essential hypertensive patients. 131
Should we screen non-syndromic pheochromocytoma paraganglioma patients for succinate dehydrogenase mutations? 131
Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects. 131
A strange chest pain after dental surgery. 130
Headache: Prevalence and relationship with office or ambulatory blood pressure in a general population sample (the Vobarno Study). 130
The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels. 130
Relationship between wall-to-lumen ratio of retimal arterioles and clinic and 24 hours blood pressure 130
I pazienti ipertesi presentano rarefazione capillare a livello del microcircolo cutaneo. 130
Relationships between plasma catecholamines, renin, age and blood pressure in essential hypertension. 129
Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol. 128
Ruolo della eme-ossigenasi nella modulazione della funzione endoteliale nelle piccole arterie di resistenza mesenteriche del ratto spontaneamente iperteso 128
Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol. 127
Determinants of the structure of resistance-sized arteries in hypertensive patients. 127
Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension. 126
ACE insertion/deletion polymorphism and cardiovascular structural phenotypes in a general population 126
Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans. 125
Supine and standing plasma catecholamines in essential hypertensive patients with different renin levels. 124
Aggressive thyroid carcinoma showing thymic-like differentiation (CASTLE): case report and review of the literature. 124
Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. 124
Altered structure of small cerebral arteries in patients with essential hypertension. 124
Remodelling of small resistance arteries in essential hypertension 124
The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects. 124
Carotid atherosclerosis in patients with primary aldosteronism and with essential hypertension 124
Effect of long-term treatment with melatonin on vascular markers of oxidative stress/inflammation and on the anticontractile activity of perivascular fat in aging mice 124
STRUCTURAL ALTERATIONS IN SUBCUTANEOUS SMALL RESISTANCE ARTERIES PREDICT CHANGES IN THE RENAL FUNCTION OF HYPERTENSIVE PATIENTS 123
Effects of insulin on endothelial and contractile function of subcutaneous small resistance arteries of hypertensive and diabetic patients. 123
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 122
Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension. 122
Effect of anti-hypertensive treatment on circulating endothelial progenitor cells in patients with mild essential hypertension. 121
Assessment of target organ damage in patients with resistant hypertension 121
Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats. 121
Prevalence of fetal-type smooth muscle cells in the media of microvessels from hypertensive patients. 120
Effect of weight loss on structural and functional alterations of subcutaneous small arteries in obese patients 120
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 120
Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertenSion. 119
Plasma catecholamines assay: comparison between fluorimetric and radioenzymatic methods. 119
Angiotensin receptor blockers and ACE inhibitors prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats. 119
Evaluation of ambulatory arterial stiffness index (AASI) and pulse wave velocity in a general population sample. The Vobarno study 119
Totale 17.910
Categoria #
all - tutte 416.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 416.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011.476 0 0 0 0 0 0 2.166 2.472 1.272 3.234 868 1.464
2020/202113.296 242 1.789 281 1.646 368 1.601 349 1.632 2.335 884 1.859 310
2021/20228.010 225 1.557 105 298 140 455 487 580 473 1.006 794 1.890
2022/20236.647 1.284 169 109 396 570 1.901 48 599 914 58 276 323
2023/20247.590 428 167 482 547 361 879 334 545 2.337 136 106 1.268
2024/20258.171 174 161 225 2.006 2.497 1.401 1.707 0 0 0 0 0
Totale 93.168